首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1609698

2025-2033 年日本重組蛋白市場報告（按產品、應用、最終用戶和地區）

Japan Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本重組蛋白IMARC Group規模達到 2.657 億美元。單株抗體、疫苗和治療性蛋白質等生物製藥的快速發展正在推動市場發展，這些藥物擴大用於治療各種疾病，包括癌症、自體免疫疾病和傳染病。

重組蛋白是透過結合不同來源的遺傳物質（通常是來自能夠產生特定蛋白質的生物體的 DNA）和宿主生物體用於蛋白質生產的細胞機制相結合而產生的人工工程蛋白質。該過程是生物技術和製藥行業不可或缺的一部分，可以大規模生產用於各種應用的特定蛋白質。為了創建重組蛋白，科學家將所需的基因序列插入宿主生物體，如細菌、酵母菌或哺乳動物細胞。一旦宿主生物體吸收了外源DNA，它就開始根據插入的遺傳指令產生目標蛋白質。重組蛋白具有多種應用，包括生產治療藥物（例如胰島素或疫苗）、研究工具（例如酵素和抗體）以及用於各種製程（例如生物燃料生產或食品加工）的工業酵素。它們的生產可以實現精確控制、可擴展性和純度，這使得它們對於推進醫療、科學和工業領域至關重要。

日本重組蛋白市場趨勢：

有幾個因素推動了日本重組蛋白市場的發展。首先，癌症、糖尿病和自體免疫疾病等慢性疾病的發生率不斷上升，對透過重組 DNA 技術生產的治療性蛋白質的需求不斷成長。因此，製藥公司正大力投資新型生物製藥的開發，推動市場向前發展。此外，基因工程和生物技術的進步改進了重組蛋白的生產過程。增強的表達系統，例如哺乳動物和酵母細胞系，能夠生產產量更高、品質更好的複雜蛋白質，從而推動市場擴張。除此之外，蛋白質體學和基因組學領域研發活動的激增增加了對重組蛋白作為研究工具的需求。這些蛋白質對於研究基因功能、蛋白質-蛋白質相互作用和藥物發現以及促進市場成長至關重要。此外，個人化醫療的採用以及雙特異性抗體和融合蛋白的開發為治療蛋白產業開闢了新的機遇，預計將在預測期內推動日本重組蛋白市場的發展。

日本重組蛋白市場細分：

產品見解：

抗體
荷爾蒙
生長因子
細胞因子
其他

應用見解：

藥物發現與開發
學術研究
生物技術研究
生物製藥生產
其他

最終使用者見解：

製藥和生物製藥公司
生技公司
學術及研究機構
合約研究組織
其他

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本重組蛋白市場迄今表現如何，未來幾年又將如何表現？
COVID-19 對日本重組蛋白市場有何影響？
日本重組蛋白市場的產品結構如何？
日本重組蛋白市場在應用上的細分如何？
日本重組蛋白市場的最終用戶細分如何？
日本重組蛋白市場價值鏈的各個階段是什麼？
日本重組蛋白的關鍵促進因素和挑戰是什麼？
日本重組蛋白市場的結構如何？
日本重組蛋白市場的競爭程度如何？

本報告回答的關鍵問題：

日本重組蛋白市場迄今表現如何，未來幾年又將如何表現？
COVID-19 對日本重組蛋白市場有何影響？
日本重組蛋白市場的產品結構如何？
日本重組蛋白市場在應用上的細分如何？
日本重組蛋白市場在最終用戶方面的詳細情形如何？
日本重組蛋白市場價值鏈的各個階段是什麼？
日本重組蛋白的關鍵促進因素和挑戰是什麼？
日本重組蛋白市場的結構如何？
日本重組蛋白市場的競爭程度如何？

抗體
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
荷爾蒙
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
生長因子
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
細胞因子
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 7 章：日本重組蛋白市場 - 細分：依應用分類

藥物發現與開發
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
學術研究
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
生物技術研究
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
生物製藥生產
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 8 章：日本重組蛋白市場 - 細分：依最終用戶分類

製藥和生物製藥公司
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
生技公司
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
學術及研究機構
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
合約研究組織
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 9 章：日本重組蛋白市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 10 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本重組蛋白市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 12 章：附錄

簡介目錄

Product Code: SR112024A19281

Japan recombinant protein market size reached USD 265.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 576.6 Million by 2033, exhibiting a growth rate (CAGR) of 9% during 2025-2033. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

Antibodies
Hormones
Growth Factors
Cytokines
Others

Application Insights:

Drug Discovery and Development
Academic Research
Biotechnology Research
Biopharmaceutical Production
Others

End User Insights:

Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan recombinant protein market?
What is the breakup of the Japan recombinant protein market on the basis of product?
What is the breakup of the Japan recombinant protein market on the basis of application?
What is the breakup of the Japan recombinant protein market on the basis of end user?
What are the various stages in the value chain of the Japan recombinant protein market?
What are the key driving factors and challenges in the Japan recombinant protein?
What is the structure of the Japan recombinant protein market and who are the key players?
What is the degree of competition in the Japan recombinant protein market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Recombinant Protein Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Hormones
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Growth Factors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Cytokines
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)

7 Japan Recombinant Protein Market - Breakup by Application

7.1 Drug Discovery and Development
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Academic Research
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Biotechnology Research
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Biopharmaceutical Production
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Recombinant Protein Market - Breakup by End User

8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Biotechnology Companies
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Academic and Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Contract Research Organization
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Recombinant Protein Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Recombinant Protein Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis